Recent advances in vascular development

Current Opinion in Hematology

Volumn 19, Issue 3, 2012, Pages 176-183

  Domigan, Courtney K ^a   Iruela Arispe, M Luisa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alagille syndrome; cerebral cavernous malformations; hemogenic endothelium; macrophage; pericyte; vascular development; vascular lumen

Indexed keywords

EPHRIN RECEPTOR; MICRORNA; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CAVERNOUS HEMANGIOMA; CELL DIFFERENTIATION; CELL INTERACTION; CELL POLARITY; CONGENITAL BLOOD VESSEL MALFORMATION; GERMLINE MICRONUCLEUS; HEMANGIOBLAST; LYMPH VESSEL ENDOTHELIUM; MACROPHAGE; MORPHOGENESIS; PATENT DUCTUS ARTERIOSUS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SOMATIC MUTATION; VASCULAR BIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; CELL COMMUNICATION; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; HEMATOPOIESIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MODELS, ANIMAL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84859842056     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283523e90     Document Type: Review

References (50)

1. Ferkowicz MJ, Yoder MC. Blood island formation: longstanding observations and modern interpretations. Exp Hematol 2005; 33:1041-1047. (Pubitemid 41226499)
2. Cao N, Yao ZX. The hemangioblast: from concept to authentication. Anat Rec (Hoboken) 2011; 294:580-588.
3. Speck NA, Iruela-Arispe ML. Conditional Cre/LoxP strategies for the study of hematopoietic stem cell formation. Blood Cells Mol Dis 2009; 43:6-11.
4. Zovein AC, Hofmann JJ, Lynch M, et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008; 3:625-636.
5. Oberlin E, El Hafny B, Petit-Cocault L, Souyri M. Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression. Int J Dev Biol 2010; 54:1165-1173.
6. Lancrin C, Sroczynska P, Stephenson C, et al. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009; 457:892-895.
7. Boisset JC, van Cappellen W, Andrieu-Soler C, et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010; 464:116-120.
8. Zovein AC, Turlo KA, Ponec RM, et al. Vascular remodeling of the vitelline artery initiates extravascular emergence of hematopoietic clusters. Blood 2010; 116:3435-3444.
9. Iacovino M, Chong D, Szatmari I, et al. HoxA3 is an apical regulator of haemogenic endothelium. Nat Cell Biol 2011; 13:72-78.
10. Sawamiphak S, Seidel S, Essmann CL, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 2010; 465:487-491.
11. Wang Y, Nakayama M, Pitulescu ME, et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010; 465:483-486.
12. Ren B, Deng Y, Mukhopadhyay A, et al. ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest 2010; 120:1217-1228.
13. Chittenden TW, Claes F, Lanahan AA, et al. Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 2006; 10:783-795. (Pubitemid 43796150)
14. Tammela T, Zarkada G, Nurmi H, et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 2011; 13:1202-1213.
15. Suá rez Y, Fernández-Hernando C, Yu J, et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008; 105:14082-14087.
16. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324:1710-1713.
17. Doebele C, Bonauer A, Fischer A, et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010; 115:4944-4950.
18. Anand S, Majeti BK, Acevedo LM, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 2010; 16:909-914.
19. Kazenwadel J, Michael MZ, Harvey NL. Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood 2010; 116:2395-2401.
20. Zovein AC, Luque A, Turlo KA, et al. Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev Cell 2010; 18:39-51.
21. Malan D, Wenzel D, Schmidt A, et al. Endothelial beta1 integrins regulate sprouting and network formation during vascular development. Development 2010; 137:993-1002.
22. Raghavan S, Bauer C, Mundschau G, et al. Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol 2000; 150:1149-1160.
23. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005; 437:275-280. (Pubitemid 41294492)
24. Xu K, Chong DC, Rankin SA, Zorn AM. Cleaver O: Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol 2009; 329:269-279.
25. Xu K, Sacharidou A, Fu S, et al. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 2011; 20:526-539.
26. Strilić B, Eglinger J, Krieg M, et al. Electrostatic cell-surface repulsion initiates lumen formation in developing blood vessels. Curr Biol 2010; 20:2003-2009.
27. Davis GE, Koh W, Stratman AN. Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Res C Embryo Today 2007; 81:270-285. (Pubitemid 351186175)
28. Newman AC, Nakatsu MN, Chou W, et al. The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 2011; 22:3791-3800.
29. Iruela-Arispe ML, Davis GE. Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 2009; 16:222-231.
30. Uyttendaele H, Ho J, Rossant J, Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 2001; 98:5643-5648. (Pubitemid 32435695)
31. Copeland JN, Feng Y, Neradugomma NK, et al. Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. BMC Dev Biol 2011; 11:12.
32. Del Curling O, Kelly DL, Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991; 75:702-708.
33. Felbor U, Sure U, Grimm T, Bertalanffy H. Genetics of cerebral cavernous angioma. Zentralbl Neurochir 2006; 67:110-116. (Pubitemid 44407798)
34. Pagenstecher A, Stahl S, Sure U, Felbor U. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 2009; 18:911-918.
35. Akers AL, Johnson E, Steinberg GK, et al. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 2009; 18:919-930.
36. Whitehead KJ, Chan AC, Navankasattusas S, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009; 15:177-184.
37. McDonald DA, Shenkar R, Shi C, et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 2011; 20:211-222.
38. Boulday G, Rudini N, Maddaluno L, et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med 2011; 208:1835-1847.
39. Louvi A, Chen L, Two AM, et al. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci USA 2011; 108:3737-3742.
40. Young WL, Kwok PY, Pawlikowska L, et al. Arteriovenous malformation. J Neurosurg 2007; 106:731-732; author reply 732-733.
41. Su H, Kim H, Pawlikowska L, et al. Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis. Am J Pathol 2010; 176:1018-1027.
42. McDaniell R, Warthen DM, Sanchez-Lara PA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79:169-173. (Pubitemid 43927389)
43. Hofmann JJ, Zovein AC, Koh H, et al. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 2010; 137:4061-4072.
44. Feng X, Krebs LT, Gridley T. Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development 2010; 137:4191-4199.
45. Nucera S, Biziato D, De Palma M. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 2011; 55:495-503.
46. Pucci F, Venneri MA, Biziato D, et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood 'resident' monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009; 114:901-914.
47. Fantin A, Vieira JM, Gestri G, et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010; 116:829-840.
48. Gordon EJ, Rao S, Pollard JW, et al. Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development 2010; 137:3899-3910.
49. Armulik A, Genové G, Mäe M, et al. Pericytes regulate the blood-brain barrier. Nature 2010; 468:557-561.
50. Han J, Lee JE, Jin J, et al. The spatiotemporal development of adipose tissue. Development 2011; 138:5027-5037.